BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 31493469)

  • 1. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
    Khan S; Ayub H; Khan T; Wahid F
    Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of components of microRNA machinery in carcinogenesis.
    Kian R; Moradi S; Ghorbian S
    Exp Oncol; 2018 Mar; 40(1):2-9. PubMed ID: 29600985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.
    Smith B; Agarwal P; Bhowmick NA
    Endocr Relat Cancer; 2017 May; 24(5):R157-R172. PubMed ID: 28289080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microRNA in forming breast carcinoma.
    Saikia M; Paul S; Chakraborty S
    Life Sci; 2020 Oct; 259():118256. PubMed ID: 32822719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of microRNA in diagnosis and treatment of ovarian cancer.
    Banno K; Yanokura M; Iida M; Adachi M; Nakamura K; Nogami Y; Umene K; Masuda K; Kisu I; Nomura H; Kataoka F; Tominaga E; Aoki D
    Biomed Res Int; 2014; 2014():232817. PubMed ID: 24822185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside.
    To KK; Tong CW; Wu M; Cho WC
    World J Gastroenterol; 2018 Jul; 24(27):2949-2973. PubMed ID: 30038463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of oncogenic miRNAs and their therapeutic importance in breast cancer.
    O'Bryan S; Dong S; Mathis JM; Alahari SK
    Eur J Cancer; 2017 Feb; 72():1-11. PubMed ID: 27997852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prioritizing cancer-related microRNAs by integrating microRNA and mRNA datasets.
    Jin D; Lee H
    Sci Rep; 2016 Oct; 6():35350. PubMed ID: 27734929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs and their role in environmental chemical carcinogenesis.
    Li M; Huo X; Davuljigari CB; Dai Q; Xu X
    Environ Geochem Health; 2019 Feb; 41(1):225-247. PubMed ID: 30171477
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Jeong W; Bae H; Lim W; Song G
    J Anim Sci; 2017 Nov; 95(11):4857-4868. PubMed ID: 29293730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying miRNA biomarkers for breast cancer and ovarian cancer: a text mining perspective.
    Li X; Dai A; Tran R; Wang J
    Breast Cancer Res Treat; 2023 Aug; 201(1):5-14. PubMed ID: 37329459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
    Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
    Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The miRNA-kallikrein interaction: a mosaic of epigenetic regulation in cancer.
    Di Meo A; Wang C; Cheng Y; Diamandis EP; Yousef GM
    Biol Chem; 2018 Sep; 399(9):973-982. PubMed ID: 29604203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
    Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
    Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer.
    Wilk G; Braun R
    Nucleic Acids Res; 2018 Feb; 46(3):1089-1101. PubMed ID: 29294105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.